Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Cantor Fitzgerald
Argus Health
Chinese Patent Office

Generated: August 22, 2017

DrugPatentWatch Database Preview

GLUCAGON Drug Profile

« Back to Dashboard

What is the patent landscape for Glucagon, and when can generic versions of Glucagon launch?

Glucagon is a drug marketed by Lilly and Fresenius Kabi Usa and is included in three NDAs.

The generic ingredient in GLUCAGON is glucagon recombinant. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glucagon recombinant profile page.

Summary for Tradename: GLUCAGON

Suppliers / Packagers: see list4
Clinical Trials: see list545
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GLUCAGON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
glucagon hydrochloride
INJECTABLE;INJECTION012122-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
glucagon hydrochloride
POWDER;INTRAMUSCULAR, INTRAVENOUS201849-001May 8, 2015RXYesYes► Subscribe► Subscribe► Subscribe
glucagon hydrochloride
INJECTABLE;INJECTION012122-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
glucagon recombinant
INJECTABLE;INJECTION020928-001Sep 11, 1998RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
US Army
Boehringer Ingelheim
Queensland Health
Daiichi Sankyo
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus